We are live on
!
Find out more
MITO
Stealth BioTherapeutics Corp. ADS
MITO
MITO
Delisted
MITO was delisted on the 15th of November, 2022.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
PM
1
Prosight Management
Dallas,
Texas
| $417K | +$748K | +336,167 | New |
|
| 2 |
BBHC
2
Brown Brothers Harriman & Co
New York
| $217K | – | – | – |
|
| 3 |
3
Renaissance Technologies
New York
| $158K | +$284K | +127,800 | New |
|
| 4 |
IC
4
Ikarian Capital
Dallas,
Texas
| $47K | – | – | – |
|
| 5 |
5
Millennium Management
New York
| $45K | +$80.1K | +36,030 | New |
|
| 6 |
PC
6
PA Capital
Richmond,
Virginia
| $28K | +$49.9K | +22,461 | New |
|
| 7 |
7
Two Sigma Investments
New York
| $15K | +$27.6K | +12,434 | New |
|
| 8 |
8
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $12K | +$21.8K | +9,800 | New |
|
| 9 |
9
Morgan Stanley
New York
| $7K | -$11.1K | -5,000 | -45% |
|
| 10 |
10
UBS Group
Zurich,
Switzerland
| $1K | -$14.7K | -6,600 | -94% |
|